Sign in

NCT01258231Recruiting

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Source: ClinicalTrials.gov · Last updated 22 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Status (registry)
Recruiting
Study type
Observational
Enrollment
4000 (estimated)
First submitted
9 Dec 2010
Start date
1 Aug 2000
Primary completion date
31 Aug 2030
Lead sponsor
Brigham and Women's Hospital
NCT number
NCT01258231

What you commit to

  • Study type: Observational
  • Planned participants: 4000
  • From 1 Aug 2000 to the primary completion date, 31 Aug 2030
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

Who the study is looking for

  • Undergoing heart surgery
  • Willing to provide consent

Age in the registry: 20 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesCompleted
UT Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesRecruiting
Department Texas Heart Institute at St. Luke's Episcopal Hospital
Coordinator of this site? Confirm its status
HoustonUnited StatesCompleted

This page is information, not medical advice. Discuss any trial with your doctor.